Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus
- 30 June 1991
- journal article
- Published by Elsevier in Metabolism
- Vol. 40 (6) , 639-644
- https://doi.org/10.1016/0026-0495(91)90057-4
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster (Mesocricetus auratus)Journal of Endocrinology, 1989
- Sexual dimorphism of hyperglycemia and glucose tolerance in Wistar fatty ratsDiabetes, 1989
- Reductions of body fat stores and total plasma cholesterol and triglyceride concentrations in several species by bromocriptine treatmentLife Sciences, 1988
- Loss of fat, water, and protein during very low calorie diets and complete starvationJournal of Molecular Medicine, 1987
- Reduction of body fat stores by inhibition of prolactin secretionCellular and Molecular Life Sciences, 1987
- Circadian and Seasonal Variations of Plasma Insulin and Cortisol Concentrations in the Syrian Hamster,Mesocricetus AuratusChronobiology International, 1987
- The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18–79 yearsJournal of Chronic Diseases, 1987
- Hyperinsulinemia in a Population at High Risk for Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1986
- Prolactin permits the expression of a circadian variation in insulin receptor profile in hepatocytes of the golden hamster (Mesocricetus auratus)Journal of Endocrinology, 1985
- Circadian rhythms of lipogenic and hypoglycaemic responses to insulin in the golden hamster (Mesocricetus auratus)Journal of Endocrinology, 1984